English | Français
English | Français
iC BIOSOLUTIONS was founded in 2019 by Pascal SURUGUE, veterinarian, and Michel UZAN, pharmaceutical executive.
Together, they combine scientific insight, industrial experience, and strategic ambition with a shared goal: to turn cutting-edge stem cell science into real-world therapies that address true unmet medical needs.
At iC BIOSOLUTIONS, we believe stem cells hold the key to a medical shift, one that moves beyond symptomatic relief. Their natural ability to repair, regenerate, and regulate tissue disorders drives our mission: to develop one of the first truly disease-modifying therapies: safe, scalable, and built for real-world use.
Our acellular therapies are designed to halt the progression of degenerative inflammatory diseases, restore tissue function, and support long-term healing.
Our lead product candidate ICB001, represents a new therapeutic class: EMA SMS ID: 300000058510.
We begin with equine osteoarthritis, an area with high unmet need and strong translational value, offering a fast, cost-effective path to proof of concept and market access. This first indication allows us to deliver a real-world product for veterinarians and horse owners, while validating both our platform, and our business model.
From this foundation, we are preparing to expand into broader applications across species and across inflammatory diseases.
iC BIOSOLUTIONS has been consistently recognized for its innovation, scientific excellence, and timely delivery of technological milestones, both at the regional and national level.
BPI France Emergence Program – Recognized as a Deep Tech company, 2019
HIPPOLIA CLUSTER – Labeled as a center of excellence, 2019
BPI FRANCE “EXCELLENCE CLUB” – Member since 2020
BPI FRANCE I-LAB NATIONAL INNOVATION AWARD – Laureate, 2020
BPI FRANCE DEEPTECH DEVELOPMENT GRANT, 2021
FRANCE RELANCE 2030 PROGRAM – Selected and awarded, 2023
PHÉNIX AWARD – University of Caen / Research–Industry partnership, 2024
NORMANDIE EQUINE VALLEY CONSORTIUM – Recognized member
This project received funding from Normandy
Region and France Government (France 2030 plan).